SubHero Banner
Text

Eylea® HD (aflibercept) – New formulation approval

August 18, 2023 - Regeneron announced the FDA approval of Eylea HD (aflibercept), for the treatment of:

  • Neovascular (Wet) age-related macular degeneration (nAMD)
  • Diabetic macular edema (DME)
  • Diabetic retinopathy (DR).

 

Download PDF

Text